drugset / Trial / NCT06751017

A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants

NCT06751017

Phase 1 Completed 16 enrolled Shionogi
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to investigate the effect of multiple-dose administration of carbamazepine on the pharmacokinetics of S-892216 in healthy adults.

Timeline

Start
2024-12-17
Primary completion
2025-02-24
Completion
2025-02-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule Oral
Subject S-892216 Unknown Oral

Indications